About: Bone safety with risedronate: histomorphometric studies at different dose levels and exposure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Bone safety with risedronate: histomorphometric studies at different dose levels and exposure Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 11 October 2014

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована в січні 2015 (uk) article scientifique publié en 2014 (fr) im Januar 2015 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 11 October 2014 (en) 2014 թվականի հոկտեմբերի 11-ին հրատարակված գիտական հոդված (hy) artículu científicu espublizáu n'ochobre de 2014 (ast)
publication date	wds:Q58970228-6D6210A1-1319-4F5E-AE78-A5A2286A559C
publication date	2014-10-11 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58970228-882A98C8-3267-4736-8198-EBE71C6047B1
language of work or name	English
exact match	wds:Q58970228-3BC2B882-0B67-4426-979B-60B9CE897BCF
exact match	https://scigraph.springernature.com/pub.10.1007/s00198-014-2850-y
cites work	wds:Q58970228-0F444CBC-92F0-43E7-8023-B75B34BC4B25 wds:Q58970228-1619AD68-E475-4608-990F-C7A3A04318BC wds:Q58970228-2437C5D3-07B7-47BE-8742-170D3CBD91AD wds:Q58970228-25498D67-C202-4B6C-B432-88BA9497F02C wds:Q58970228-31080014-64DC-4BB9-A4CC-2CA9561D11C5 wds:Q58970228-32391F9D-53A7-43C8-AAC4-57FB6B2EAF8C wds:Q58970228-39807CE7-A84A-4D34-A935-BBCF62709BD2 wds:Q58970228-44DA732F-C9D1-4268-8EED-CF833F5B5BF4 wds:Q58970228-5C059CCD-30F4-4C65-A35E-5DE8EB491509 wds:Q58970228-6F37E08C-91AD-491F-B91D-8D1034C063B7 wds:Q58970228-700AA879-BE21-41A4-BFED-54FD39FA8057 wds:Q58970228-718F97E5-068E-4956-A7CB-2E99EBC3BE7E wds:Q58970228-75EBDBF0-0CFE-4B06-9867-908E5FE1D1D6 wds:Q58970228-765783B0-B8E3-4526-A525-872BE88499A4 wds:Q58970228-775930DF-44AE-4715-B323-0C81FEFDF31D wds:Q58970228-7943D4BA-4FE3-41B9-92FB-40595AB49772 wds:Q58970228-7A983B66-9B7D-4F4E-A08D-09ED819471BA wds:Q58970228-7AFECD80-0667-4236-AA22-B371079CC656 wds:Q58970228-7C73DCBB-21A0-4994-8307-4DF4B100CE98 wds:Q58970228-828FD970-E72D-45B6-8576-B5DD40FD6F8F wds:Q58970228-8E51CD03-89A1-4F49-9A77-133337711E24 wds:Q58970228-9515E2EC-0C37-4521-8E8C-CF46EF2A7D81 wds:Q58970228-AB541AF3-24B4-4EB4-BA44-83CB4FA65896 wds:Q58970228-AEFAFCDC-F01C-46ED-AB7F-5CF9F34134F8 wds:Q58970228-B48BCAC5-5A9D-4F75-9174-EF5178E58356 wds:Q58970228-B7139849-95CE-4BAD-BB71-70D84E372D56 wds:Q58970228-B7D25FE8-0980-4588-A937-3011FB42009D wds:Q58970228-BC3EA010-420D-4B50-9FB3-273F649A7239 wds:Q58970228-C0B2FA5E-099D-4F82-902E-4BEBF022D71D wds:Q58970228-C3CC5EBE-BBFC-4710-A628-D3BAE76E159E wds:Q58970228-C51FB5D1-2CA3-49F6-AFB5-1112FF448A58 wds:Q58970228-E87A814A-C647-4E16-AB6F-FC39A69EA058 wds:Q58970228-F5BA5E20-5E6C-42C0-9F50-D235118EFFBE wds:Q58970228-F97819C9-FC0D-4232-8B4A-DF7D41212E78
cites work	Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients Targeted and nontargeted remodeling Remodeling and skeletal fragility Bisphosphonate mechanism of action Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Tetracycline-based histological analysis of bone remodeling The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised r Severely suppressed bone turnover: a potential complication of alendronate therapy Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee Expansion of the medullary cavity at the expense of cortex in postmenopausal osteoporosis Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis Treatment of osteoporosis with denosumab Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. Risedronate reduces intracortical porosity in women with osteoporosis. Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females Issues in modern bone histomorphometry Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet Implications of architecture for the pathogenesis and prevention of vertebral fracture A novel monthly dosing regimen of risedronate for the treatment of postmenopausal osteoporosis: 2-year data
author name string	wds:Q58970228-117AA409-1B6B-404D-A132-F4FDAE759299 wds:Q58970228-1DCD0764-0C29-49A3-8F88-AD323618F730 wds:Q58970228-55570433-E48E-4AB1-9283-6DC0B8AA7F25 wds:Q58970228-5D68AF22-F2A3-4F6C-88D0-A8CAA638312E
author name string	P Chavassieux R R Recker M W Lundy L-G Ste-Marie
rdfs:label	Bone safety with risedronate: histomorphometric studies at different dose levels and exposure (en) Bone safety with risedronate: histomorphometric studies at different dose levels and exposure (nl)
skos:prefLabel	Bone safety with risedronate: histomorphometric studies at different dose levels and exposure (en) Bone safety with risedronate: histomorphometric studies at different dose levels and exposure (nl)
name	Bone safety with risedronate: histomorphometric studies at different dose levels and exposure (en) Bone safety with risedronate: histomorphometric studies at different dose levels and exposure (nl)
author	wds:Q58970228-2B8A127D-D807-4CFF-B8F4-00DDD71C1301
author	Michael McClung
title	wds:Q58970228-225057D3-C7A8-473A-A8EF-7F984651DFED

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software